Kezar Life Sciences Inc (KZR)
0.79
-0.01
(-1.42%)
USD |
NASDAQ |
Apr 25, 16:00
0.7922
0.00 (0.00%)
After-Hours: 20:00
Kezar Life Sciences Total Liabilities (Quarterly): 33.66M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 33.66M |
| September 30, 2023 | 33.33M |
| June 30, 2023 | 31.10M |
| March 31, 2023 | 31.69M |
| December 31, 2022 | 29.70M |
| September 30, 2022 | 21.58M |
| June 30, 2022 | 20.14M |
| March 31, 2022 | 19.55M |
| December 31, 2021 | 21.06M |
| September 30, 2021 | 11.41M |
| June 30, 2021 | 9.786M |
| March 31, 2021 | 11.70M |
| December 31, 2020 | 10.86M |
| Date | Value |
|---|---|
| September 30, 2020 | 10.89M |
| June 30, 2020 | 10.00M |
| March 31, 2020 | 11.99M |
| December 31, 2019 | 11.47M |
| September 30, 2019 | 11.03M |
| June 30, 2019 | 10.66M |
| March 31, 2019 | 10.91M |
| December 31, 2018 | 5.885M |
| September 30, 2018 | 6.14M |
| June 30, 2018 | 6.33M |
| March 31, 2018 | 6.809M |
| December 31, 2017 | 79.91M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
9.786M
Minimum
Jun 2021
33.66M
Maximum
Dec 2023
18.51M
Average
11.99M
Median
Mar 2020
Total Liabilities (Quarterly) Benchmarks
| Accuray Inc | 428.70M |
| Tonix Pharmaceuticals Holding Corp | 48.93M |
| Acumen Pharmaceuticals Inc | 43.15M |
| NovaBay Pharmaceuticals Inc | 5.72M |
| Palatin Technologies Inc | 24.94M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 221.24M |
| Shareholders Equity (Quarterly) | 187.57M |